REMS Industry Consortium (RIC)

Partner

The REMS Industry Consortium, Inc. (RIC) is a nonprofit organization that brings together the perspectives of organizations that sell, or anticipate selling, prescription drugs or biologics subject to Risk Evaluation and Mitigation Strategies (REMS).

The RIC seeks to:

- Foster and encourage two-way communication between manufacturers/REMS sponsors and FDA
- Discuss and clarify challenges faced by industry sponsors and the FDA
- Identify best practices for REMS throughout the development, review, and management lifecycle
- Provide the FDA with a "sounding board" to solicit feedback on REMS
- Collectively explore vendor participation and capabilities in REMS

website